In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach
DOI10.1007/S11538-011-9693-XzbMATH Open1402.92240OpenAlexW2007150539WikidataQ51525907 ScholiaQ51525907MaRDI QIDQ417370FDOQ417370
Authors: Wenyong Hu, Wei-Rong Zhong, Feng-Hua Wang, Yuanzhi Shao, Li Li 
Publication date: 14 May 2012
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s11538-011-9693-x
Recommendations
- On the dynamics of tumor-immune system interactions and combined chemo- and immunotherapy
- Modelling pulsed immunotherapy of tumour-immune interaction
- A mathematical model of tumor-immune system dynamics combined with radiotherapy illustrating a potential synergism
- Mathematical modelling and analysis of the tumor treatment regimens with pulsed immunotherapy and chemotherapy
- Mathematical modeling of an immune checkpoint inhibitor and its synergy with an immunostimulant
numerical simulationnonlinear dynamicspreclinical pharmacokinetics evaluationsynergism and antagonismtumour
Medical applications (general) (92C50) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)
Cites Work
- Mathematical biology. Vol. 1: An introduction.
- Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
- Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function
- OPTIMAL CONTROL OF MIXED IMMUNOTHERAPY AND CHEMOTHERAPY OF TUMORS
- Title not available (Why is that?)
- Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes
- Different strategies for cancer treatment: mathematical modelling
Cited In (3)
- A machine learning framework for predicting synergistic and antagonistic drug combinatorial efficacy
- Modelling the immune response to cancer: an individual-based approach accounting for the difference in movement between inactive and activated T cells
- Antagonism and negative side-effects in combination therapy for cancer
This page was built for publication: In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q417370)
